Stay updated on A(B)VD+Nivolumab in Frontline for HL Clinical Trial
Sign up to get notified when there's something new on the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page.

Latest updates to the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedFooter revision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision label updated to v3.4.3 from v3.4.2.SummaryDifference0.0%

- Check68 days agoChange DetectedUpdates shown are limited to changes in the study record's date entries (new dates such as 2026-02-17, 2026-02-13, 2027-01, 2026-02 and deletions like 2025-11-20, 2026-01, 2025-11-19, 2025-11), with no changes to study design, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check75 days agoChange DetectedRevision metadata updated to v3.4.2. The earlier maintenance notice about government funding lapse and the v3.4.1 revision were removed.SummaryDifference0.4%

- Check82 days agoChange DetectedAn updated site-wide notice about government funding lapse and NIH Clinical Center operations was added, with a link to opm.gov for status updates. A new Revision: v3.4.1 replaces the previous v3.4.0.SummaryDifference0.4%

Stay in the know with updates to A(B)VD+Nivolumab in Frontline for HL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page.